Childhood Acute Lymphoblastic Leukemia Treatment - National Cancer Institute
Links shared publicly online about this topic.
- 868total visits
Childhood Acute Lymphoblastic Leukemia Treatment - National Cancer Institute
View full resource at cancer.gov
Tags: Cancer, Leukemia, Children's Health
Most Recently Shared on September 16, 2010 at 11:33 pm By:
Acute lymphoblastic leukemia recovery: Factors that affect prognosis & treatment options: http://bit.ly/bvtHmR
Researchers develop first 'theranostic' treatment for acute lymphoblastic leukemia (ALL)
eurekalert.org — “A team of researchers at Case Western Reserve University School of Medicine has developed the first "theranostic" agent for the treatment of acute lymphoblastic leukemia (ALL). ALL is the most common type of childhood cancer diagnosed in approximately 5,000 new cases each year in the United States.” View full resource at eurekalert.org
Most Recently Shared on March 12, 2012 at 7:02 pm By:
Researchers develop first 'theranostic' treatment for acute lymphoblastic leukemia (ALL) http://t.co/tZwb3Qfq
When leukemia returns, gene that mediates response to key drug often mutated
labspaces.net — “Despite dramatically improved survival rates for childhood acute lymphoblastic leukemia (ALL), relapse remains a leading cause of death from the disease. Work led by St. Jude Children's Research Hospital investigators identified mutations in a gene named CREBBP that may help the cancer resist steroid treatment and fuel ALL's return.” View full resource at labspaces.net
Most Recently Shared on March 10, 2011 at 6:09 pm By:
When leukemia returns, gene that mediates response to key drug often mutated - http://is.gd/2QYpJL
Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return
news-medical.net — “Despite dramatically improved survival rates for childhood acute lymphoblastic leukemia, relapse remains a leading cause of death from the disease. Work led by St. Jude Children's Research Hospital investigators identified mutations in a gene named CREBBP that may help the cancer resist steroid treatment and fuel ALL's return.” View full resource at news-medical.net
Most Recently Shared on March 10, 2011 at 11:44 am By:
Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return: Despite dramatically impr... http://bit.ly/idsrJf
Gene that mediates response to key cancer drugs frequently mutated in young leukemia patients who relapse
sciencedaily.com — “Despite dramatically improved survival rates for childhood acute lymphoblastic leukemia (ALL), relapse remains a leading cause of death from the disease. Researchers have now identified mutations in a gene named CREBBP that may help the cancer resist steroid treatment and fuel ALL's return.” View full resource at sciencedaily.com
Most Recently Shared on March 10, 2011 at 2:19 am By:
Gene that mediates response to key cancer drugs frequently mutated in young leukemia patients who relapse: Despi... http://bit.ly/gvFB6V
When Leukemia Returns, Gene That Mediates Response to Key Drug Often Mutated
newswise.com — “Despite dramatically improved survival rates for childhood acute lymphoblastic leukemia (ALL), relapse remains a leading cause of death from the disease. Work led by St. Jude Children--™s Research Hospital investigators identified mutations in a gene named CREBBP that may help the cancer resist steroid treatment and fuel ALL--™s return.” View full resource at newswise.com
Most Recently Shared on March 9, 2011 at 6:44 pm By:
newswise Health Communicator and Health News
When Leukemia Returns, Gene That Mediates Response to Key Drug Often Mutated: Despite dramatically improved surv... http://bit.ly/gNUTrT
When Leukemia Returns, Gene That Mediates Response to Key Drug Often Mutated
newswise.com — “Despite dramatically improved survival rates for childhood acute lymphoblastic leukemia (ALL), relapse remains a leading cause of death from the disease. Work led by St. Jude Children--™s Research Hospital investigators identified mutations in a gene named CREBBP that may help the cancer resist steroid treatment and fuel ALL--™s return.” View full resource at newswise.com
Most Recently Shared on March 9, 2011 at 6:40 pm By:
#health news: When Leukemia Returns, Gene That Mediates Response to Key Drug Often Mutated: Despite dramatically... http://bit.ly/gvu11C
When Leukemia Returns, Gene That Mediates Response to Key Drug Often Mutated
newswise.com — “Despite dramatically improved survival rates for childhood acute lymphoblastic leukemia (ALL), relapse remains a leading cause of death from the disease. Work led by St. Jude Children--™s Research Hospital investigators identified mutations in a gene named CREBBP that may help the cancer resist steroid treatment and fuel ALL--™s return.” View full resource at newswise.com
Most Recently Shared on March 9, 2011 at 6:18 pm By:
When Leukemia Returns, Gene That Mediates Response to Key Drug Often Mutated: Despite dramatically impro... http://bit.ly/hkDA0S #cancer
Intensive chemotherapy can dramatically boost survival of older teenage leukemia patients
sciencedaily.com — “More effective risk-adjusted chemotherapy and sophisticated patient monitoring helped push cure rates to nearly 88 percent for older adolescents enrolled in an acute lymphoblastic leukemia (ALL) treatment protocol and closed the survival gap between older and younger patients battling the most common childhood cancer.” View full resource at sciencedaily.com
Most Recently Shared on December 21, 2010 at 2:44 am By:
Intensive chemotherapy can dramatically boost survival of older teenage leukemia patients http://bit.ly/fyr8Xy
Intensive Chemotherapy Can Dramatically Boost Survival of Older Teenage Leukemia Patients
newswise.com — “More effective risk-adjusted chemotherapy and sophisticated patient monitoring helped push cure rates to nearly 88 percent for older adolescents enrolled in a St. Jude Children--™s Research Hospital acute lymphoblastic leukemia (ALL) treatment protocol and closed the survival gap between older and younger patients battling the most common childhood cancer.” View full resource at newswise.com
Most Recently Shared on December 20, 2010 at 11:27 pm By:
newswise Health Communicator and Health News
Intensive Chemotherapy Can Dramatically Boost Survival of Older Teenage Leukemia Patients: More effective risk-a... http://bit.ly/hS7RnW
A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Elena J. Ladas. 2009; Cancer - Wiley InterScience
www3.interscience.wiley.com — “A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Elena J. Ladas. 2009; Cancer - Wiley InterScience” View full resource at www3.interscience.wiley.com
Most Recently Shared on December 14, 2009 at 3:42 pm By:
ACS Journal Cancer Medical Journal
Milk thistle reduces liver toxicity associated with chemotherapy http://bit.ly/5jkWya
Cancer Researchers Identify New Mutant Genes
physorg.com — “(PhysOrg.com) -- University of New Mexico Cancer Center researchers have identified a genetic mutation underlying one of the most common childhood cancers, acute lymphoblastic leukemia (ALL). The discovery could lead to more effective treatments for a subset of ALL patients who experience minimal benefit ...” View full resource at physorg.com
Most Recently Shared on June 3, 2009 at 9:25 pm By:
Cancer Researchers Identify New Mutant Genes http://tinyurl.com/ozjlfb
Advertisement
